) has been revised to $4.20 / share. This is an increase of 10.75% from the prior estimate of $3.79 dated January 11, 2026. The price target is an average of many targets provided by analysts. The ...
Century Therapeutics (NASDAQ:IPSC – Free Report) had its target price cut by HC Wainwright from $5.00 to $2.00 in a research report report published on Thursday morning,Benzinga reports. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results